Skip to content
TrialScanner

NCT06349759

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

Phase 3CompletedIRDLeadVTRSCollaborator

Registry record

Lead sponsor
Opus Genetics, Inc
Conditions
Mesopic Vision; Night Vision Loss
Primary completion
Apr 17, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06349759 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06349759: Safety and Efficacy of 0.75%... | TrialScanner